Could the blood of COVID-19 patients be used to predict disease progression?

Researchers from Charité – Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms. These biomarker profiles could be used to predict disease progression and make it easier for doctors to decide which type of treatment to use. The work has been published in Cell Systems*.